Administration Would Pay Less Than Pfizer Price For Other Vaccines

By John Wilkerson / July 30, 2020 at 7:23 PM
A senior administration official on Thursday (July 30) implied that the $19.95 per dose price that HHS committed to pay Pfizer for its coronavirus vaccine candidate is higher than what other companies would get because Pfizer paid its own development costs, would handle much of the distribution and will be paid only if the vaccine works. However, the government will not continue buying from Pfizer if vaccines being developed with taxpayer money are approved. The administration held a press call...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.